73
Views
0
CrossRef citations to date
0
Altmetric
Special Report

Current dilemmas in the diagnosis and management of follicular thyroid tumors

, , , , &
Pages 379-385 | Received 05 Apr 2016, Accepted 27 Jul 2016, Published online: 18 Aug 2016

References

  • Hundahl SA, Cady B, Cunningham MP, et al. Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the united states during 1996. U.S. and German Thyroid Cancer Study Group. An American College of Surgeons Commission on Cancer Patient Care Evaluation study. Cancer. 2000;89(1):202–217.
  • Hedinger CE, Williams ED, Sobin LH. Histological typing of thyroid tumours. In: Hedinger CE, editor. International histological classification of tumours. Vol. 11. Berlin: Springer; 1988. p. 7–68.
  • Asari R, Koperek O, Scheuba C, et al. Follicular thyroid carcinoma in an iodine-replete endemic goiter region: a prospectively collected, retrospectively analyzed clinical trial. Ann Surg. 2009;249(6):1023–1031.
  • Degroot LJ, Kaplan EL, Shukla MS, et al. Morbidity and mortality in follicular thyroid cancer. J Clin Endocrinol Metab. 1995;80(10):2946–2953.
  • Livolsi VA, Asa SL. The demise of follicular carcinoma of the thyroid gland. Thyroid. 1994;4(2):233–236.
  • Ghossein R. Encapsulated malignant follicular cell-derived thyroid tumors. Endocr Pathol. 2010;21(4):212–218.
  • Shin JH, Han B-K, Ko EY, et al. Differentiation of widely invasive and minimally invasive follicular thyroid carcinoma with sonography. Eur J Radiol. 2010;74(3):453–457.
  • Miyakawa M, Onoda N, Etoh M, et al. Diagnosis of thyroid follicular carcinoma by the vascular pattern and velocimetric parameters using high resolution pulsed and power Doppler ultrasonography. Endocr J. 2005;52(2):207–212.
  • Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133.
  • Cibas ES, Ali SZ. The Bethesda System for reporting thyroid cytopathology. Am J Clin Pathol. 2009;132(5):658–665.
  • Wang CC, Friedman L, Kennedy GC, et al. A large multicenter correlation study of thyroid nodule cytopathology and histopathology. Thyroid. 2011;21(3):243–251.
  • Xing M, Haugen BR, Schlumberger M. Progress in molecular-based management of differentiated thyroid cancer. Lancet. 2013;381(9871):1058–1069.
  • Nikiforov YE, Ohori NP, Hodak SP, et al. Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples. J Clin Endocrinol Metab. 2011;96(11):3390–3397.
  • Nikiforov YE, Steward DL, Robinson-smith TM, et al. Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. J Clin Endocrinol Metab. 2009;94(6):2092–2098.
  • Chudova D, Wilde JI, Wang ET, et al. Molecular classification of thyroid nodules using high-dimensionality genomic data. J Clin Endocrinol Metab. 2010;95(12):5296–5304.
  • Alexander EK, Kennedy GC, Baloch ZW, et al. Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. N Engl J Med. 2012;367(8):705–715.
  • Li H, Robinson KA, Anton B, et al. Cost-effectiveness of a novel molecular test for cytologically indeterminate thyroid nodules. J Clin Endocrinol Metab. 2011;96(11):1719–1726.
  • Mciver B, Castro MR, Morris JC, et al. An independent study of a gene expression classifier (Afirma) in the evaluation of cytologically indeterminate thyroid nodules. J Clin Endocrinol Metab. 2014;99(11):4069–4077.
  • Lee L, How J, Tabah RJ, et al. Cost-effectiveness of molecular testing for thyroid nodules with atypia of undetermined significance cytology. J Clin Endocrinol Metab. 2014;99(8):2674–2682.
  • Scheiden R, Keipes M, Bock C, et al. Thyroid cancer in Luxembourg: a national population-based data report (1983-1999). BMC Cancer. 2006;6:102.
  • Clerici T, Kolb W, Beutner U, et al. Diagnosis and treatment of small follicular thyroid carcinomas. Br J Surg. 2010;97(6):839–844.
  • Ruegemer JJ, Hay ID, Bergstralh EJ, et al. Distant metastases in differentiated thyroid carcinoma: a multivariate analysis of prognostic variables. J Clin Endocrinol Metab. 1988;67(3):501–508.
  • Chow SM, Law SC, Au SK, et al. Differentiated thyroid carcinoma: comparison between papillary and follicular carcinoma in a single institute. Head Neck. 2002;24(7):670–677.
  • Machens A, Holzhausen HJ, Dralle H. The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma. Cancer. 2005;103(11):2269–2273.
  • Tan MP, Agarwal G, Reeve TS, et al. Impact of timing on completion thyroidectomy for thyroid cancer. Br J Surg. 2002;89(6):802–804.
  • Glockzin G, Hornung M, Kienle K, et al. Completion thyroidectomy: effect of timing on clinical complications and oncologic outcome in patients with differentiated thyroid cancer. World J Surg. 2012;36(5):1168–1173.
  • Erbil Y, Bozbora A, Ademoglu E, et al. Is timing important in thyroid reoperation? J Otolaryngol Head Neck Surg. 2008;37(1):56–64.
  • Sitges-Serra A, Ruiz S, Girvent M, et al. Outcome of protracted hypoparathyroidism after total thyroidectomy. Br J Surg. 2010;97(11):1687–1695.
  • Goffredo P, Cheung K, Roman SA, et al. Can minimally invasive follicular thyroid cancer be approached as a benign lesion?: a population-level analysis of survival among 1,200 patients. Ann Surg Oncol. 2013;20(3):767–772.
  • Zaydfudim V, Feurer ID, Griffin MR, et al. The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma. Surgery. 2008;144(6):1070–1077.
  • Shaha A, Gleich L, Di Maio T, et al. Accuracy and pitfalls of frozen section during thyroid surgery. J Surg Oncol. 1990;44(2):84–92.
  • Huang C-C, Hsueh C, Liu F-H, et al. Diagnostic and therapeutic strategies for minimally and widely invasive follicular thyroid carcinomas. Surg Oncol. 2011;20(1):1–6.
  • Udelsman R, Westra WH, Donovan PI, et al. Randomized prospective evaluation of frozen-section analysis for follicular neoplasms of the thyroid. Ann Surg. 2001;233(5):716–722.
  • Schmid KW, Farid NR. How to define follicular thyroid carcinoma? Virchows Arch. 2006;448(4):385–393.
  • Wynford-Thomas D. Thyroid cancer. In: Lemoine N, Neoptolemos J, Cooke T, editors. A molecular approach. Oxford: Blackwell Scientific; 1994. p. 192–222.
  • Hermann M, Tonninger K, Kober F, et al. Minimally invasive follicular thyroid carcinoma: not always total thyroidectomy. Chirurg. 2010;81(7):627-30, 632-635.
  • Thompson LD, Wieneke JA, Paal E, et al. A clinicopathologic study of minimally invasive follicular carcinoma of the thyroid gland with a review of the English literature. Cancer. 2001;91(3):505–524.
  • Heffess CS, Thompson LD. Minimally invasive follicular thyroid carcinoma. Endocr Pathol. 2001;12(4):417–422.
  • Hirokawa M, Carney JA, Goellner JR, et al. Observer variation of encapsulated follicular lesions of the thyroid gland. Am J Surg Pathol. 2002;26(11):1508–1514.
  • Ghossein R. Update to the College of American Pathologists reporting on thyroid carcinomas. Head Neck Pathol. 2009;3(1):86–93.
  • DeLellis RA, Lloyd RV, Heitz PU, et al. WHO classification of tumours. Pathology and genetics of tumours of endocrine organs. Lyon: IARC press; 2004. p. 73–76.
  • Lang W, Choritz H, Hundeshagen H. Risk factors in follicular thyroid carcinomas. A retrospective follow-up study covering a 14-year period with emphasis on morphological findings. Am J Surg Pathol. 1986;10(4):246–255.
  • Rosai J. Handling of thyroid follicular patterned lesions. Endocr Pathol. 2005;16(4):279–283.
  • D’Avanzo A, Ituarte P, Treseler P, et al. Prognostic scoring systems in patients with follicular thyroid cancer: a comparison of different staging systems in predicting the patient outcome. Thyroid. 2004;14(6):453–458.
  • D’Avanzo A, Treseler P, Ituarte PH, et al. Follicular thyroid carcinoma: histology and prognosis. Cancer. 2004;100(6):1123–1129.
  • Cipriani NA, Nagar S, Kaplan SP, et al. Follicular thyroid carcinoma: how have histologic diagnoses changed in the last half-century and what are the prognostic implications? Thyroid. 2015;25(11):1209–1216.
  • Dionigi G, Kraimps JL, Schmid KW, et al. Minimally invasive follicular thyroid cancer (MIFTC)–a consensus report of the European Society of Endocrine Surgeons (ESES). Langenbecks Arch Surg. 2014;399(2):165–184.
  • Lundgren CI, Hall P, Dickman PW, et al. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study. Cancer. 2006;106(3):524–531.
  • Sitges-Serra A. Low-risk papillary thyroid cancer: times are changing. Expert Rev Endocr Metab. 2014;9(1):9–18.
  • Ríos A, Rodríguez JM, Ferri B, et al. Are prognostic scoring systems of value in patients with follicular thyroid carcinoma? Eur J Endocrinol. 2013;169(6):821–827.
  • Loh KC, Greenspan FS, Gee L, et al. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients. J Clin Endocrinol Metab. 1997;82(11):3553–3562.
  • Ito Y, Hirokawa M, Masuoka H, et al. Prognostic factors of minimally invasive follicular thyroid carcinoma: extensive vascular invasion significantly affects patient prognosis. Endocr J. 2013;60(5):637–642.
  • Alfalah H, Cranshaw I, Jany T, et al. Risk factors for lateral cervical lymph node involvement in follicular thyroid carcinoma. World J Surg. 2008;32(12):2623–2626.
  • van Heerden JA, Hay ID, Goellner JR, et al. Follicular thyroid carcinoma with capsular invasion alone: a nonthreatening malignancy. Surgery. 1992;112(6):1130–1136.
  • Sacks W, Fung CH, Chang JT, et al. The effectiveness of radioactive iodine for treatment of low-risk thyroid cancer: a systematic analysis of the peer-reviewed literature from 1966 to April 2008. Thyroid. 2010;20(11):1235–1245.
  • Ballal S, Soundararajan R, Garg A, et al. Intermediate-risk differentiated thyroid carcinoma patients who were surgically ablated do not need adjuvant radioiodine therapy: long-term outcome study. Clin Endocrinol (Oxf). 2016;84(3):408–416.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.